Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|AZD0424||BCR-ABL Inhibitor 25 SRC Inhibitor 29||AZD0424 is a tyrosine kinase inhibitor of Abl and Src kinases, which may result in apoptosis and tumor growth inhibition (PMID: 25662515, PMID: 17704648).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||no benefit||AZD0424||Phase I||Actionable||In a Phase I trial, AZD0424 treatment in patients with advanced solid tumors did not result in antitumor activity and is not recommended for further testing as a monotherapy in advanced solid tumor patients (PMID: 29438361).||29438361|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|